- The CDC awarded Helix a new contract to research how genetics affect COVID-19 vaccine efficacy. The research, according to Daniel Lee, Helix’s senior vice president of life sciences and growth, will provide new insight into the adverse effects of long COVID-19.
- A recent study looking at the duration of symptoms from long COVID-19 highlighted that while a majority of symptoms ease within one year, others, specifically loss of taste and smell, have been found to last longer.
- New research led by Stephanie Richard, PhD, Simon Pollett, and Anthony Fries, PhD, unveiled that vaccination — even after the onset of COVID-19 infection — lowers risk factors associated with long COVID-19, including risk for pulmonary, diabetes, neurological and mental health encounters.
- The effects of long COVID-19 are now being felt across the U.S. workforce, according to a Jan. 24 report from the New York State Insurance Fund. Of the 3,139 COVID-19-related compensation claims the fund examined, 31 percent involved individuals with long COVID-19.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.